HISTORY

1945

  • Biofarma laboratory has been established by Evcim family.

1950 - 1989

  • It started production in Mercan, Istanbul.

1973

  • Pharmacist Mustafa Öncel from Konya becomes partners with his friend from faculty of pharmacy Pharmacist Ata Evcim.

1976

  • Biofarma was sold fully to Öncel family.

1984

  • Launching to our product PIYELOSEPTYL which is still an unrivalled product in urinary tract infections.

1986

  • Launching to our product KATARIN which is one of the most important brands of cold market.

1990

  • Relocated from Mercan to Sancaktepe for a first modern facility which has a 15.000m2 usable space.

1991

  • Launching to our product MUKORAL which is one of the most important brands of the market.
  • Launching to our product CIPRO which is our 25 years old brand which is a market leader.

1994

  • Launching to our product ANDAZOL.

1995

  • Launching to our product NIPIDOL.

1996

  • Launching to our product OSMOLAK.

1998

  • Biofarma has become an incorporated company.

1999

  • Launching to our product FULSAC.
  • Launching to our product LARICID.

2000

  • Launching to our product ADRENALIN.
  • Launching to our product ATROPIN SULFAT.
  • Launching to our product MAGNEZYUM SULFAT.
  • Launching to our product POTASYUM KLORUR.

2001

  • Launching to our product CARENA.
  • Launching to our product CEFADAY.

2002

  • Launching to our product LANZEDIN which is one of the most important brands of cold market.

2003

  • Launching to our product AZELTIN.

2004

  • Launching to our product ALARIN.
  • Launching to our product PRIMPERAN.

2005

  • Launching to our product LOXIBIN.
  • Launching to our product ROSENDA.

2006

  • Biofarma transferred partnership to Citi Venture Capital International (CVCI) and PILS (Partners in life Sciences).
  • Launching to our product CORBINAL.
  • Launching to our product ZINCOVER.
     

2007

  • Launching to our product CHOLVAST.
  • Launching to our product LOXIBIN PLUS.
  • Launching to our product MEKSUN.
  • Launching to our product NEVOTEK.

2008

  • Launching to our product ARYPEZ.
  • Launching to our product EPSILE.
  • Launching to our product GISMOTAL.
  • Launching to our product PANREF.
  • Launching to our product RICUS.
  • Launching to our product TIOPRAM.
  • Launching to our product ZYZAPIN.

2009

  • Launching to our product AIRLAST.
  • Launching to our product GABASET and with this step Biofarma stepped into neuropathic pain market.
  • Launching to our product MOXIFOR.
  • Launching to our product RISTART.
  • Launching to our product VETRIA.

2010

  • Biofarma manufacturing facilities obtained confirmation of export suitability from Belarus health ministry.
  • Launching to our product ATERVIX.
  • Launching to our product DIAFREE.
  • Launching to our product KOLEZ.
  • Launching to our product NOROMAT.
  • Launching to our product TEGLIX.
  • Launching to our product TOLDIN.

2011

  • Launching to our product DESRINAL.
  • Launching to our product EBITEX.
  • Launching to our product ETOXA.
  • Launching to our product GLUFORCE.
  • Launching to our product LUSTEC.
  • Launching to our product PIOFORCE.

2012

  • Launching to our product ZIZOLID.

2013

  • Launching to our product COMBO.
  • Launching to our product KETINEL.
  • Biofarma manufacturing facilities obtained confirmation of export suitability from Northern Iraq health ministry.

2014

  • Biofarma incorporated S.a.r.l. Lux.
  • Biofarma manufacturing facilities obtained confirmation of export suitability for Europe from MHRA – UK inspection.
  • Launching to our product CRELIX.
  • Launching to our product LYPRE. And with this step Biofarma expanded its portfolio in neuropathic pain market.

2015

  • Launching to our product CLOBESOL & TRODERM. And with this step Biofarma stepped into dermatology market.
  • Launching to our product OPEMIN. And with this step Biofarma stepped into nootropics market.
  • Biofarma manufacturing facilities obtained confirmation of export suitability from Ukraine inspection.

WARNING!

This section is only for "Health Professionals".

Are you a health professional?